NEW YORK (GenomeWeb) – The Mayo Clinic and IBM this week announced a pilot program to use IBM's Watson to match patients with clinical trials.
The initiative is in its proof-of-concept stage and Watson is being familiarized with clinical trial terms. Further down the road, genetic and genomic information may be included in the patient-matching process, a Mayo Clinic spokesperson told GenomeWeb Daily News.